Vol 4 No 4(13) (2011)

Vol 4 No 3(12) (2011)

Vol 4 No 2(11) (2011)

Vol 4 No 1(10) (2011)

Vol 3 No 4(9) (2010)

Vol 3 No 3(8) (2010)

Vol 3 No 2(7) (2010)

Vol 3 No 1(6) (2010)

Vol 2 No 4(5) (2009)

Vol 2 No 3(4) (2009)

Vol 2 No 2(3) (2009)

Vol 2 No 1(2) (2009)

Vol 1 No 1(1) (2008)

Suplement 1
2023

Vildagliptin – the unique DPP-4 inhibitor of the class

Sitagliptin and its position in contemporary management of type 2 diabetes mellitus

Ahead of print